Found: 328
Select item for more details and to access through your institution.
Considerations in the Design of Clinical Trials for Cognitive Aging.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2012, v. 67, n. 7, p. 766, doi. 10.1093/gerona/gls124
- By:
- Publication type:
- Article
Considerations in the design of clinical trials for cognitive aging.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Alzheimer's Prevention Initiative: A Plan to Accelerate the Evaluation of Presymptomatic Treatments.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 26, p. 321, doi. 10.3233/JAD-2011-0059
- By:
- Publication type:
- Article
Alzheimer's Prevention Initiative: A Plan to Accelerate the Evaluation of Presymptomatic Treatments.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 26, p. 321
- By:
- Publication type:
- Article
Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [<sup>18</sup>F]FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 22, n. 4, p. 1241, doi. 10.3233/JAD-2010-100939
- By:
- Publication type:
- Article
Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Reduced Posterior Cingulate Mitochondrial Activity in Expired Young Adult Carriers of the APOE ℇ4 Allele, the Major Late-Onset Alzheimer's Susceptibility Gene.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 22, n. 1, p. 307, doi. 10.3233/JAD-2010-100129
- By:
- Publication type:
- Article
Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease.
- Published in:
- Journal of Alzheimer's Disease, 2006, v. 9, n. 3, p. 225, doi. 10.3233/JAD-2006-9301
- By:
- Publication type:
- Article
Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 5, p. 1, doi. 10.15252/emmm.202217123
- By:
- Publication type:
- Article
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 6, p. 1, doi. 10.15252/emmm.202114022
- By:
- Publication type:
- Article
Contribution of alpha‐synuclein pathology to cerebral glucose metabolism in patients with amnestic MCI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 10, p. 7411, doi. 10.1002/alz.14151
- By:
- Publication type:
- Article
Genetic associations with dementia‐related proteinopathy: Application of item response theory.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 2906, doi. 10.1002/alz.13741
- By:
- Publication type:
- Article
Harmonizing florbetapir and PiB PET measurements of cortical Aβ plaque burden using multiple regions‐of‐interest and machine learning techniques: An alternative to the Centiloid approach.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 3, p. 2165, doi. 10.1002/alz.13677
- By:
- Publication type:
- Article
Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 3, p. 1839, doi. 10.1002/alz.13532
- By:
- Publication type:
- Article
A multi‐class deep learning model to estimate brain age while addressing systematic bias of regression to the mean.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082691
- By:
- Publication type:
- Article
A 2.5D residual U‐Net for improved amyloid PET harmonization preserving spatial information.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082690
- By:
- Publication type:
- Article
Informed consent process experience in Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease Colombia trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082483
- By:
- Publication type:
- Article
The health economics of an Alzheimer's prevention therapy.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.072696
- By:
- Publication type:
- Article
Statistical innovations in the API ADAD Colombia trial: a randomized, double‐blind, placebo‐controlled, parallel‐group study in cognitively unimpaired PSEN1 E280A mutation carriers evaluating efficacy and safety of crenezumab.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.070863
- By:
- Publication type:
- Article
Effect of Alcohol Use on Progression to Mild Cognitive Impairment and Dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074355
- By:
- Publication type:
- Article
Florbetapir amyloid PET in cognitively impaired former professional and college American football players.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077854
- By:
- Publication type:
- Article
Fluid Biomarkers for Neurobehavioral Dysregulation in Former American Football Players.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077858
- By:
- Publication type:
- Article
No Interaction Between BDNF Val66Met and APOE ε4 on PET‐Based Amyloid and Tau Measurements.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.072076
- By:
- Publication type:
- Article
Florbetapir PET Uptake in White Matter in Aging and Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079283
- By:
- Publication type:
- Article
Florbetapir PET Measurements of Amyloid Plaque Deposition are More Closely Correlated with Cross‐Sectional and Longitudinal Cognitive and Clinical Measurements Using a White Matter Reference Region of Interest.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078608
- By:
- Publication type:
- Article
Plasma biomarkers, memory impairment, and imaging measures of Alzheimer's disease in American Indians.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074282
- By:
- Publication type:
- Article
Ethnoracial differences in the prevalence of amyloid abnormality.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079159
- By:
- Publication type:
- Article
APOE3 Christchurch heterozygosity delays clinical onset in autosomal dominant Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.073020
- By:
- Publication type:
- Article
APOE3 Christchurch heterozygosity delays clinical onset in autosomal dominant Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.073020
- By:
- Publication type:
- Article
IC‐P‐025: FEASIBILITY OF QUANTIFYING AMYLOID BURDEN USING VOLUMETRIC MRI DATA: PRELIMINARY FINDINGS BASED ON THE DEEP LEARNING 3D CONVOLUTIONAL NEURAL NETWORK APPROACH.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 14, p. P30, doi. 10.1016/j.jalz.2018.06.2089
- By:
- Publication type:
- Article
IC‐P‐026: QUANTIFICATION OF AMYLOID BURDEN FROM FLORBETAPIR PET IMAGES WITHOUT USING TARGET AND REFERENCE REGIONS: PRELIMINARY FINDINGS BASED ON THE DEEP LEARNING 3D CONVOLUTIONAL NEURAL NETWORK APPROACH.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 14, p. P31, doi. 10.1016/j.jalz.2018.06.2090
- By:
- Publication type:
- Article
IC‐P‐010: COMPARING CEREBRAL WHITE MATTER, CEREBELLAR, AND PONTINE REFERENCE REGIONS TO CHARACTERIZE FLORBETAPIR PET MEASUREMENTS OF AMYLOID‐β BURDEN IN PSEN1 E280A MUTATION CARRIERS AND NONCARRIERS FROM THE COLOMBIAN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE KINDRED
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 14, p. P20, doi. 10.1016/j.jalz.2018.06.2074
- By:
- Publication type:
- Article
IC‐P‐003: RELATIONSHIPS BETWEEN MEAN CORTICAL AMYLOID BURDEN AND REGIONAL GRAY MATTER REDUCTIONS IN ALZHEIMER'S DEMENTIA, MILD COGNITIVE IMPAIRMENT AND UNIMPAIRED OLDER ADULTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 14, p. P15, doi. 10.1016/j.jalz.2018.06.2067
- By:
- Publication type:
- Article
Longitudinal lumbar puncture adherence in the Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Colombia Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.065233
- By:
- Publication type:
- Article
Electrocardiogram differences in cognitively unimpaired PSEN1‐E280A carriers and non‐carriers from the Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Colombia Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.064023
- By:
- Publication type:
- Article
MRI signatures of Brain Age in the Alzheimer's disease continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.063418
- By:
- Publication type:
- Article
Transfer learning based deep encoder decoder network for amyloid PET harmonization with small datasets.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.062947
- By:
- Publication type:
- Article
Increased spatial extent of cerebral tau PET elevations in former NFL and college football players from the DIAGNOSE CTE Research Project.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.060872
- By:
- Publication type:
- Article
Volume atrophy in medial temporal cortex and verbal memory scores in American Indians: Data from the Strong Heart Study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 6, p. 2298, doi. 10.1002/alz.12889
- By:
- Publication type:
- Article
A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 5, p. 1938, doi. 10.1002/alz.12843
- By:
- Publication type:
- Article
Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 2, p. 696, doi. 10.1002/alz.12737
- By:
- Publication type:
- Article
API ADAD Colombia Trial initial findings: a randomized, double‐blind, placebo‐controlled, parallel‐ group study in cognitively unimpaired PSEN1 E280A mutation carriers evaluating efficacy and safety of crenezumab.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.069724
- By:
- Publication type:
- Article
Effects of Oral ALZ‐801, an Amyloid Oligomer Inhibitor, on Plasma Biomarkers in APOE4 Carriers with Early Alzheimer's Disease: Results of Six‐month Interim Analysis from a Phase 2 Biomarker Study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.069141
- By:
- Publication type:
- Article
Clinical Profiles of Persons Who Progress to Cognitive Impairment in the Alzheimer's Prevention Initiative (API) ADAD Colombia Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 7, p. 1, doi. 10.1002/alz.069107
- By:
- Publication type:
- Article
Serotonin Reuptake Inhibitors are Associated with Less Amyloid‐β Burden Spatial Extent in Military Veterans with only PTSD, but not with TBI or Comorbid PTSD/TBI: Preliminary PET Findings from ADNI‐DOD Project.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.068811
- By:
- Publication type:
- Article
Head‐to‐Head Comparison of Four Plasma Phospho‐Tau Immunoassays in the Neuropathological Diagnosis of Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.060336
- By:
- Publication type:
- Article
Plasma neurofilament light chain in cognitively unimpaired late middle‐aged & older adult APOE ε4 homozygotes, heterozygotes, & non‐carriers from the Arizona APOE Cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.060091
- By:
- Publication type:
- Article